Diabetic blindness could be reversed with eye injection according to an article in the Telegraph, the first new treatment for people with proliferative diabetic retinopathy
Optos plc (LSE: OPTS), a leading medical retinal imaging company, has announced the results of a clinical validation study comparing Optos ultra-widefield imaging to Early
The latest issue of the magazine is out. We hear from four graduates of the DAFNE education courses for people with T1 diabetes. Plus, news,
As reported by Glycosomedia: A team of engineers and scientists at the University of British Columbia has developed a device that can be implanted behind
